Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder.

PubWeight™: 2.43‹?› | Rank: Top 2%

🔗 View Article (PMID 22622291)

Published in J ECT on June 01, 2012

Authors

Xiaobin Wang1, Yunliang Chen, Xian Zhou, Fenghua Liu, Tao Zhang, Chunxiang Zhang

Author Affiliations

1: Department of Anesthesiology, Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan Province, China. wangxiaobin67@yahoo.cn

Associated clinical trials:

Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy | NCT02579642

Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy | NCT02305394

Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy | NCT01935115

Articles citing this

Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology (Berl) (2014) 2.37

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front Pharmacol (2013) 1.25

Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. Annu Rev Pharmacol Toxicol (2014) 1.21

Antidepressant effect of the first electroconvulsive therapy with ketamine and/or propofol. J ECT (2013) 1.09

Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci (2013) 1.09

Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy. Ther Adv Psychopharmacol (2014) 1.06

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder. J Neural Transm (Vienna) (2013) 0.98

Neuroplasticity and the next wave of antidepressant strategies. Front Cell Neurosci (2013) 0.92

Ketofol-Dexmedetomidine combination in ECT: A punch for depression and agitation. Indian J Anaesth (2014) 0.86

Is ketamine-propofol mixture (ketofol) an appropriate alternative induction agent for electroconvulsive therapy? Saudi J Anaesth (2013) 0.80

A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depression. Sci Rep (2016) 0.80

Antidepressant Effect of Combined Ketamine and Electroconvulsive Therapy on Patients With Major Depressive Disorder: A Randomized Trial. Iran J Psychiatry Behav Sci (2015) 0.78

The Incidence and Predictors of Headache and Myalgia in Patients After Electroconvulsive Therapy (ECT). Anesth Pain Med (2016) 0.77

Antidepressant effect of the first electroconvulsive therapy with ketamine and/or propofol: response. J ECT (2013) 0.77

Impact of ketamine on learning and memory function, neuronal apoptosis and its potential association with miR-214 and PTEN in adolescent rats. PLoS One (2014) 0.77

Intraoperative optical mapping of epileptogenic cortices during non-ictal periods in pediatric patients. Neuroimage Clin (2016) 0.77

Effect of Ketamine, Thiopental and Ketamine-Thiopental Combination during Electroconvulsive Therapy for Depression. Turk J Anaesthesiol Reanim (2015) 0.77

Effect of intraoperative application of ketamine on postoperative depressed mood in patients undergoing elective orthopedic surgery. J Anesth (2015) 0.76

Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression. Drugs (2017) 0.75

Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders. Curr Behav Neurosci Rep (2015) 0.75

General Anaesthesia Protocols for Patients Undergoing Electroconvulsive Therapy: Retrospective analysis of 504 sessions over a five-year period at a tertiary care hospital in Oman. Sultan Qaboos Univ Med J (2017) 0.75

Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial. Lancet Psychiatry (2017) 0.75

A Randomized Pilot Study Comparing Ketamine and Methohexital Anesthesia for Electroconvulsive Therapy in Patients With Depression. J ECT (2017) 0.75

Effects of sevoflurane or ketamine on the QTc interval during electroconvulsive therapy. J Anesth (2014) 0.75

S -ketamine compared to etomidate during electroconvulsive therapy in major depression. Eur Arch Psychiatry Clin Neurosci (2017) 0.75

Anaesthesia for electroconvulsive therapy: An overview with an update on its role in potentiating electroconvulsive therapy. Indian J Anaesth (2017) 0.75

Articles by these authors

(truncated to the top 100)

A global map of p53 transcription-factor binding sites in the human genome. Cell (2006) 20.65

ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature (2009) 18.38

MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res (2007) 7.98

Metagenomic discovery of biomass-degrading genes and genomes from cow rumen. Science (2011) 6.93

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res (2009) 6.43

RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer. J Clin Oncol (2011) 6.30

Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet (2003) 5.99

Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet (2007) 5.85

MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol (2007) 4.65

ChIP-Seq identification of weakly conserved heart enhancers. Nat Genet (2010) 4.32

MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res (2009) 4.25

A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res (2009) 3.37

MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem (2009) 3.34

MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol (2009) 3.19

Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science (2002) 3.13

Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res (2010) 2.77

Rnnotator: an automated de novo transcriptome assembly pipeline from stranded RNA-Seq reads. BMC Genomics (2010) 2.62

Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell (2011) 2.58

A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol (2012) 2.54

Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell (2004) 2.29

Direct-method SAD phasing of proteins enhanced by the use of intrinsic bimodal phase distributions in the subsequent phase-improvement process. Acta Crystallogr D Biol Crystallogr (2009) 2.28

A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond) (2010) 2.18

Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem (2012) 2.16

Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J Biol Chem (2009) 2.08

Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer (2006) 2.04

Single-atom catalysis of CO oxidation using Pt1/FeOx. Nat Chem (2011) 1.98

Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res (2010) 1.96

CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J Biol Chem (2006) 1.96

Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate. J Biol Chem (2003) 1.94

Inducible lineage-specific deletion of TbetaRII in fibroblasts defines a pivotal regulatory role during adult skin wound healing. J Invest Dermatol (2008) 1.92

MicroRNA-21 in cardiovascular disease. J Cardiovasc Transl Res (2010) 1.90

The airborne metagenome in an indoor urban environment. PLoS One (2008) 1.81

Comparative study of four time series methods in forecasting typhoid fever incidence in China. PLoS One (2013) 1.78

Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. Clin Cancer Res (2004) 1.76

Mortality risk from squamous cell skin cancer. J Clin Oncol (2005) 1.74

Identification of ancient remains through genomic sequencing. Genome Res (2008) 1.72

Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol (2010) 1.69

Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med (2005) 1.67

A novel systematic error compensation algorithm based on least squares support vector regression for star sensor image centroid estimation. Sensors (Basel) (2011) 1.64

Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells. Cancer Biol Ther (2009) 1.61

Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol (2007) 1.61

A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment. J Med Chem (2011) 1.58

Model-based segmentation of medical imagery by matching distributions. IEEE Trans Med Imaging (2005) 1.57

Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer. J Clin Oncol (2006) 1.57

CCN2 is necessary for the function of mouse embryonic fibroblasts. Exp Cell Res (2006) 1.57

SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Cancer Res (2007) 1.57

Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol (2011) 1.54

Impurity effect on weak antilocalization in the topological insulator Bi2Te3. Phys Rev Lett (2011) 1.53

Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support. Ann Thorac Surg (2011) 1.52

Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study. J Pain Symptom Manage (2005) 1.52

Control of basal autophagy by calpain1 mediated cleavage of ATG5. Autophagy (2010) 1.51

Fatigue-induced damage in Zr-based bulk metallic glasses. Sci Rep (2013) 1.49

Anterior versus posterior approach for treatment of thoracolumbar burst fractures: a meta-analysis. Eur Spine J (2013) 1.49

Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem Biophys (2007) 1.49

Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy. J Thorac Oncol (2007) 1.48

A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression. Br J Haematol (2003) 1.47

A novel combined SLAM based on RBPF-SLAM and EIF-SLAM for mobile system sensing in a large scale environment. Sensors (Basel) (2011) 1.46

Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts. Matrix Biol (2007) 1.46

Unexpected pro-injury effect of propofol on vascular smooth muscle cells with increased oxidative stress. Crit Care Med (2011) 1.45

Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol (2006) 1.45

Fabrication of uniform core-shell structural calcium and titanium precipitation particles and enhanced electrorheological activities. Nanotechnology (2009) 1.43

Highly efficient extraction of serum peptides by ordered mesoporous carbon. Angew Chem Int Ed Engl (2011) 1.43

PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation. Mol Cell Neurosci (2002) 1.43

Active contours for tracking distributions. IEEE Trans Image Process (2004) 1.42

A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo. Mol Cancer Ther (2013) 1.42

Regulation of alpha-cell function by the beta-cell during hypoglycemia in Wistar rats: the "switch-off" hypothesis. Diabetes (2004) 1.41

Anterior versus posterior routes of reconstruction after esophagectomy: a comparative anatomic study. Ann Thorac Surg (2009) 1.40

Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling. Autophagy (2011) 1.40

Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo. Diabetes (2007) 1.39

Genome-wide identification of regulatory DNA elements and protein-binding footprints using signatures of open chromatin in Arabidopsis. Plant Cell (2012) 1.38

Laparoscopic treatment for small intestinal bleeding: a report of 77 cases. J Laparoendosc Adv Surg Tech A (2010) 1.38

Imidazolopiperazines: hit to lead optimization of new antimalarial agents. J Med Chem (2011) 1.36

Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature (2013) 1.35

Access to palliative care among patients treated at a comprehensive cancer center. Oncologist (2012) 1.34

Blockade of nuclear factor of activated T cells activation signaling suppresses balloon injury-induced neointima formation in a rat carotid artery model. J Biol Chem (2005) 1.33

Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells. Am J Pathol (2006) 1.33

Colonic crypt changes during adenoma development in familial adenomatous polyposis: immunohistochemical evidence for expansion of the crypt base cell population. Am J Pathol (2004) 1.33

Redox homeostasis: the linchpin in stem cell self-renewal and differentiation. Cell Death Dis (2013) 1.31

Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. Blood (2004) 1.28

New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential. Drug Resist Updat (2009) 1.27

Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope (2005) 1.27

One family cluster of avian influenza A(H7N9) virus infection in Shandong, China. BMC Infect Dis (2014) 1.26

Snail is critical for tumor growth and metastasis of ovarian carcinoma. Int J Cancer (2010) 1.26

Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer. Clin Cancer Res (2008) 1.24

A translational study of urine miRNAs in acute myocardial infarction. J Mol Cell Cardiol (2012) 1.24

Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid. Mol Cell (2010) 1.23

Single-atom catalysts: a new frontier in heterogeneous catalysis. Acc Chem Res (2013) 1.23

Imidazolopiperazines: lead optimization of the second-generation antimalarial agents. J Med Chem (2012) 1.22

Targeted agent use in cancer patients at the end of life. J Pain Symptom Manage (2012) 1.22

Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003. BMC Infect Dis (2004) 1.21

Endoscopic management of benign tracheobronchial tumors. J Thorac Dis (2011) 1.21

Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance. Gynecol Oncol (2007) 1.21

Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII. Cancer Biol Ther (2006) 1.20

FAK is required for TGFbeta-induced JNK phosphorylation in fibroblasts: implications for acquisition of a matrix-remodeling phenotype. Mol Biol Cell (2007) 1.19

Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor. Clin Cancer Res (2008) 1.19

microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int J Oncol (2011) 1.18

FGFR4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer. Cancer Res (2013) 1.16

MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J Biol Chem (2011) 1.16

An essential role for gp130 in neointima formation following arterial injury. Circ Res (2007) 1.15

Regulation of centrosome separation in yeast and vertebrates: common threads. Trends Cell Biol (2009) 1.15